Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64601 - 64625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Raloxifene	Approved Investigational	PSMD14	10213	downregulated	Raloxifene Hydrochloride results in decreased expression of PSMD14 mRNA	2q24.2	A20479
Raloxifene	Approved Investigational	PSMD6	9861	downregulated	Raloxifene Hydrochloride results in decreased expression of PSMD6 mRNA	3p14.1	A20479
Raloxifene	Approved Investigational	PSME4	23198	downregulated	Raloxifene Hydrochloride results in decreased expression of PSME4 mRNA	2p16.2	A20479
Raloxifene	Approved Investigational	PTGES	9536	downregulated	Raloxifene Hydrochloride results in decreased expression of PTGES mRNA	9q34.11	A21106
Raloxifene	Approved Investigational	PTGS2	5743	downregulated	Raloxifene Hydrochloride results in decreased expression of PTGS2 mRNA	1q31.1	A21307
Raloxifene	Approved Investigational	PTGS2	5743	upregulated	Raloxifene Hydrochloride results in increased expression of PTGS2 mRNA	1q31.1	A21307
Raloxifene	Approved Investigational	PTPN13	5783	upregulated	Raloxifene Hydrochloride results in increased expression of PTPN13 mRNA	4q21.3	A23831
Raloxifene	Approved Investigational	PYY	5697	upregulated	Raloxifene Hydrochloride results in increased expression of PYY mRNA	17q21.31	A21116
Raloxifene	Approved Investigational	RAB11B	9230	upregulated	Raloxifene Hydrochloride results in increased expression of RAB11B mRNA	19p13.2	A21112
Raloxifene	Approved Investigational	RAB2A	5862	upregulated	Raloxifene Hydrochloride results in increased expression of RAB2A mRNA	8q12.1-q12.2	A20482
Raloxifene	Approved Investigational	RAB40C	57799	upregulated	Raloxifene Hydrochloride results in increased expression of RAB40C mRNA	16p13.3	A21112
Raloxifene	Approved Investigational	RACGAP1	29127	downregulated	Raloxifene Hydrochloride results in decreased expression of RACGAP1 mRNA	12q13.12	A20479
Raloxifene	Approved Investigational	RAP1A	5906	downregulated	Raloxifene Hydrochloride results in decreased expression of RAP1A mRNA	1p13.2	A20479
Raloxifene	Approved Investigational	RAPGEFL1	51195	downregulated	Raloxifene Hydrochloride results in decreased expression of RAPGEFL1 mRNA	17q21.1	A21106
Raloxifene	Approved Investigational	RASEF	158158	downregulated	Raloxifene Hydrochloride results in decreased expression of RASEF mRNA	9q21.32	A21112
Raloxifene	Approved Investigational	RB1	5925	downregulated	Raloxifene Hydrochloride results in decreased expression of RB1 mRNA	13q14.2	A21112
Raloxifene	Approved Investigational	RBBP7	5931	downregulated	Raloxifene Hydrochloride results in decreased expression of RBBP7 mRNA	Xp22.2	A20479
Raloxifene	Approved Investigational	RBBP8	5932	downregulated	Raloxifene Hydrochloride results in decreased expression of RBBP8 mRNA	18q11.2	A21106
Raloxifene	Approved Investigational	RBM10	8241	upregulated	Raloxifene Hydrochloride results in increased expression of RBM10 mRNA	Xp11.3	A23827
Raloxifene	Approved Investigational	RCL1	10171	downregulated	Raloxifene Hydrochloride results in decreased expression of RCL1 mRNA	9p24.1	A21106
Raloxifene	Approved Investigational	RET	5979	downregulated	Raloxifene Hydrochloride results in decreased expression of RET mRNA	10q11.21	A21106
Raloxifene	Approved Investigational	RHBDF1	64285	upregulated	Raloxifene Hydrochloride results in increased expression of RHBDF1 mRNA	16p13.3	A21106
Raloxifene	Approved Investigational	RND3	390	downregulated	Raloxifene Hydrochloride results in decreased expression of RND3 mRNA	2q23.3	A23827
Raloxifene	Approved Investigational	ROM1	6094	upregulated	Raloxifene Hydrochloride results in increased expression of ROM1 mRNA	11q13	A21164
Raloxifene	Approved Investigational	RPL6	6128	downregulated	Raloxifene Hydrochloride results in decreased expression of RPL6 mRNA	12q24.13	A20479

Displaying entries 64601 - 64625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability